GBS patients (n = 100) | Controls (n = 90/56) | p value | ||||
---|---|---|---|---|---|---|
Any reactivity | Strong reactivity | Any reactivity | Strong reactivity | Any reactivity | Strong reactivity | |
Neuroblastoma neurons IgG | 11 (11%) | 2 (2%) | 10/90 (11.1%) | 0/90 (0.0%) | > 0.999 (ns) | 0.499 (ns) |
Neuroblastoma neurons IgM | 28 (28%) | 8 (8%) | 11/90 (12.2%) | 2/90 (2.2%) | 0.011 (*) | 0.105 (ns) |
DRG neurons IgG | 32 (32%) | 6 (6%) | 6/90 (6.7%) | 0/90 (0.0%) | < 0.0001 (***) | 0.030 (*) |
DRG neurons IgM | 34 (34%) | 11 (11%) | 22/90 (24.4%) | 2/90 (2.2%) | 0.156 (ns) | 0.020 (*) |
Monkey peripheral nerve IgG | 56 (56%) | 17 (17%) | 30/56 (53.6%) | 3/56 (5.4%) | 0.8669 (ns) | 0.0455 (*) |
Monkey peripheral nerve IgM | 44 (44%) | 10 (10%) | 20/56 (35.7%) | 6/56 (10.7%) | 0.3964 (ns) | > 0.999 (ns) |